Warrants (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Warrants (Details) [Line Items]
Received from cash exercises (in Dollars)			$ 172,950
Warrant to purchase shares of common stock			1,555,160
Issued shares of common stock upon cashless			3,997,661
Warrants to purchase shares of common stock			12,686,249
Purchase aggregate of shares	26,000,000
Additional shares of common stock			2,729,734,691
Shares of common stock per share (in Dollars per share)			$ 0.00224
Deemed dividends value (in Dollars)		$ 95,838,488	$ 28,933,472
Additional paid in capital was increased (in Dollars)		$ 95,838,488	28,933,472
Debt, description		From December 23 to December 30, 2020, the Company issued 654.78 shares of Series Y Preferred Stock, having a stated value of $13,095,636, in exchange for convertible notes payable of $5,775,767 (net of debt discount of $133,608), accrued interest of $3,625,237, and 14,764,624,721 warrants. The exchanges resulted in a reduction of derivative liabilities related to the convertible notes and accrued interest of $92,934,419, a reduction of derivative liabilities related to the warrants of $72,892,563, and a net gain on settlement of $162,132,350.
Aggregate intrinsic value of outstanding stock warrants (in Dollars)			$ 14,804,944
Stock price per share (in Dollars per share)		$ 0.0063
Series A Preferred Stock [Member]
Warrants (Details) [Line Items]
Aggregate shares of preferred stock	6,000
Series B Preferred Stock [Member]
Warrants (Details) [Line Items]
Warrant to purchase shares of common stock			600,551,672
Warrants to purchase shares of common stock			568,118,340
Per share stock (in Dollars per share)			$ 0.075
Exercise price per share (in Dollars per share)			0.00224
Repriced to per share (in Dollars per share)			$ 0.00224